Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2/3 2

Status

Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 4FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 4Head & Neck 1

Conditions

Prostatic Neoplasms 59Neoplasm Metastasis 5Prostate Cancer Metastatic 3Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 3Adenocarcinoma 3Prostate CA 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Metastatic Hormone-sensitive Prostate Cancer 2Metastatic Castration-resistant Prostate Cancer 2Urologic Diseases 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stage IV Prostate Adenocarcinoma AJCC v7 1Salivary Gland Neoplasms 1Recurrence 1Radiation Injuries 1Prostatic Diseases 1PSA Level Greater Than 0.03 1Oligometastatic Prostate Cancer 1Neoplasms 1Neoplasm Recurrence, Local 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Metastatic Hormone-Sensitive Prostate Cance 1Metastatic Hormone Sensitive Prostate Cancer 1Metastatic Castrate-sensitive Prostate Cancer 1Lymphatic Metastasis 1Intraprostatic Prostate Cancer 1Hormone Sensitive Prostate Cancer 1Genital Neoplasms, Male 1Gastrointestinal Diseases 1

Interventions

pembrolizumab 105Specimen Handling 55Magnetic Resonance Spectroscopy 48Biopsy 47Nivolumab 40Paclitaxel 35Gemcitabine 30Radiosurgery 29Carboplatin 28Irinotecan 22Ipilimumab 22Cyclophosphamide 22Cisplatin 22trastuzumab deruxtecan 21Leucovorin 19Capecitabine 19Fluorouracil 18Cetuximab 18Bevacizumab 18130-nm albumin-bound paclitaxel 18Pemetrexed 17Fulvestrant 17Drug Therapy 16Docetaxel 16Taxes 15Oxaliplatin 15olaparib 14abemaciclib 14Radiotherapy 14palbociclib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Androgen Antagonists × 1 year × Clear all
NCT03644303 2026-05-14

TRAP

Royal Marsden NHS Foundation Trust

Phase NA Completed
86 enrolled 27 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting
464 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT07426094 2026-03-23

PRO-BOOST-N

Affidea Nu-med Center of Oncological DIagnostics and Therapy

Phase 2/3 Recruiting
1,600 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02454543 2026-01-12

g-RAMPP

Martini-Klinik am UKE GmbH

Phase NA Active not recruiting
452 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02069730 2026-01-08

A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes

University Health Network, Toronto

Phase NA Completed
114 enrolled
Head & Neck

Neoplasm Metastasis, Neoplasms, Recurrence, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡